Responses

Download PDFPDF
Long term outcome in patients with silent versus symptomatic ischaemia during dobutamine stress echocardiography
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Prognosis of patients with silent versus symptomatic myocardial ischemia
    • Don Poldermans, Professor of Medicine
    • Other Contributors:
      • Elena Biagini, MD, Ron van Domburg, PhD, Jeroen J. Bax, MD

    Dear Editor,

    We do appreciate Dr Tsakok's concern regarding the correct use of the two-sample-t-test. At our centre it is common use to apply the Kolmogorv-Smirnov test to test the normality assumption in all our analyses. In our study this test was not significant and therefore, we were allowed to use the parametric tests such as the two sample t-test. The method Dr Tsakok is proposing is unknown to us. We are not...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Comment on heart analyses

    Dear Editor,

    Biagini et al (1), Rodriguez et al (2) and Dursunglu et al (3) illustrate incorrect statistical analyses, by using the two-sample t-test. This compares normal means assuming unknown but equal variances. While the Central Limit Theorem justifies normality for mean inferences, making it unnecessary to test (3) for normality, unknown variances need not be homogeneous. This makes the two-sample t-test un...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    More work on this needed

    Dear Editor,

    To suggest that “patients with asymptomatic ischaemia should be treated with a complete medical therapy or revascularisation as patients with symptomatic myocardial ischaemia” is a little too strong a recommendation to make from an observational study. The topic of your paper is of vital interest, but surely a randomised-controlled trial is needed with clinically important end-points? Potential confou...

    Show More
    Conflict of Interest:
    None declared.